{"database": "openregs", "table": "documents", "rows": [["FDA-2005-D-0140-0014", "FDA", "FDA-2005-D-0140", "Reference 3 FDA Memorandum to All Registered Blood Establishments: \u201cRevised Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV),\u201d August 5, 1993.", "Supporting & Related Material", "Background Material", "2017-12-28T05:00:00Z", 2017, 12, null, null, "2017-12-28T20:40:33Z", null, 0, 0, "0900006482d7ee41"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-D-0140-0014"], "units": {}, "query_ms": 0.43238094076514244, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}